查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566179

软骨修復市场规模、份额、成长分析、按治疗方式、按应用、按应用场所、按地区 - 行业预测，2024-2031 年

Cartilage Repair Market Size, Share, Growth Analysis, By Treatment Modality, By Application, By Application site, By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球软骨修復市场规模约为10亿美元，预计将从2023年的12.5亿美元达到2031年的43.8亿美元，预测期内（2024-2031年）的复合年增长率为17%。

由于肌肉骨骼疾病盛行率的上升、关节健康意识的增强以及再生医学的进步，全球软骨修復市场正在经历显着增长。软骨损伤通常是由创伤、过度使用和骨关节炎等退化性疾病引起的，这增加了对有效修復解决方案的需求。容易遭受软骨损伤的老年人口不断增加，以及各年龄层运动相关损伤的增加，进一步推动了市场的发展。几种创新技术已成为软骨修復的可行选择，包括自体软骨细胞移植术（ACI）、微骨折、自体骨软骨移植和合成支架的开发。该市场的主要参与者不断投资于研发，以开发侵入性较小且持久的治疗方法。此外，医疗保健提供者正在关注微创手术，以缩短復原时间并改善患者的治疗效果。政府和医疗机构正在透过报销政策和研究计划资助来促进再生疗法的采用。儘管成长潜力巨大，但该市场面临治疗成本高、监管核准严格和程序复杂等挑战。高伤害復发率和有限的熟练专业人员进一步限制了市场。然而，随着3D生物列印和干细胞治疗等技术进步，以及个人化医疗的日益普及，软骨修復市场有望在未来几年强劲成长。

目录

介绍

  • 研究目的
  • 定义
  • 市场范围

调查方法

  • 资讯采购
  • 二手资料来源和主要资料来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 市场概况展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 供应链分析
  • 监管环境
  • 专利分析
  • 技术分析

软骨修復市场：依治疗方式分类

  • 市场概况
  • 基于细胞的软骨修復/软骨再生
    • 软骨细胞移植
    • 生长因子
    • 干细胞
  • 去细胞软骨修復/软骨再生
    • 组织支架
    • 无细胞复合材料

软骨修復市场：按应用部位

  • 市场概况
  • 膝盖
  • 髋关节
  • 脚踝和脚
  • 其他应用部分

软骨修復市场：依应用分类

  • 市场概况
  • 透明软骨
  • 纤维软骨

软骨修復市场规模：按地区

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位（2023年）
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市场占有率（2023年）

主要企业简介

  • DePuy Synthes（Johnson & Johnson）
  • Zimmer Biomet Holdings Inc.
  • Smith & Nephew plc
  • Vericel Corporation
  • Osiris Therapeutics Inc.
  • Histogenics Corporation
  • Anika Therapeutics Inc.
  • Arthrex Inc.
  • B. Braun Melsungen AG
  • Stryker Corporation
  • CONMED Corporation
  • Orthocell Limited
  • RTI Surgical Holdings Inc.
  • MEDIPOST Co. Ltd.
  • CellGenix GmbH
  • Tissue Regenix Group plc
  • CollPlant Biotechnologies Ltd.
  • ISTO Technologies Inc.
  • MTF Biologics
  • CartiHeal Ltd.
简介目录
Product Code: SQMIG35D2072

Global Cartilage Repair Market size was valued at around 1 billion in 2022 and is expected to rise from USD 1.25 billion in 2023 to reach a value of USD 4.38 billion by 2031, at a CAGR of 17% over the forecast period (2024-2031).

The global cartilage repair market has experienced substantial growth due to the rising prevalence of musculoskeletal diseases, increasing awareness about joint health, and advancements in regenerative medicine. Cartilage damage, often caused by trauma, overuse, or degenerative conditions like osteoarthritis, has led to a growing demand for effective repair solutions. The market is further fueled by the expanding elderly population, which is more prone to cartilage injuries, and the rise in sports-related injuries across all age groups. Several innovative techniques, such as autologous chondrocyte implantation (ACI), microfracture, osteochondral autografts, and the development of synthetic scaffolds, have emerged as viable options for cartilage restoration. Key players in this market are continuously investing in research and development to create less invasive and more durable treatments. Additionally, healthcare providers are focusing on minimally invasive surgeries that reduce recovery time and enhance patient outcomes. Governments and healthcare organizations are promoting the adoption of regenerative therapies through reimbursement policies and funding for research initiatives. Despite the significant growth potential, the market faces challenges such as high treatment costs, stringent regulatory approvals, and the complexity of cartilage repair procedures. The high recurrence rate of injuries and the limited availability of skilled professionals further constrain the market. However, with technological advancements, such as 3D bioprinting and stem cell therapy, and the increasing popularity of personalized medicine, the cartilage repair market is poised for robust growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cartilage Repair Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cartilage Repair Market Segmental Analysis

Global Cartilage Repair Market is segmented by Treatment Modality, Application, Application Site, and region. Based on Treatment Modality, the market is segmented into Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-cell-based (Tissue Scaffolds, Cell-free Composites). Based on Application, the market is segmented into Knee, Hip, Ankle and Foot, and Other Application Sites. Based on Application Site, the market is segmented into Hyaline Cartilage, Fibrocartilage. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Cartilage Repair Market

One of the key drivers propelling the global cartilage repair market is the rapid advancement in regenerative medicine, particularly in cell-based therapies and tissue engineering. Innovations such as autologous chondrocyte implantation (ACI), stem cell therapies, and gene editing have significantly improved the efficacy of cartilage repair treatments. These technologies focus on regenerating cartilage tissue by using the body's own cells or bioengineered tissues, reducing the chances of rejection and improving long-term outcomes. Furthermore, the development of biomaterials and scaffolds that mimic the natural cartilage environment has enhanced the ability to restore joint function and prevent further damage. With the integration of 3D bioprinting and tissue scaffolding, researchers are now able to precisely reconstruct cartilage structures, paving the way for more personalized and effective treatments. The increasing collaboration between biotechnology firms, research institutes, and healthcare providers has also accelerated clinical trials, resulting in faster commercialization of advanced cartilage repair therapies.

Restraints in the Global Cartilage Repair Market

Despite the advancements in cartilage repair, the high cost of procedures remains a significant restraint for the market. Treatments such as autologous chondrocyte implantation (ACI) and stem cell therapies involve complex processes, including the extraction, cultivation, and implantation of cells, which drive up the overall costs. Additionally, the need for specialized equipment, skilled surgeons, and postoperative care contributes to the high expenses associated with these treatments. For instance, ACI, one of the most effective cartilage repair methods, can cost tens of thousands of dollars, making it inaccessible to many patients, especially in low- and middle-income regions. Moreover, in several countries, these procedures are not fully covered by insurance, placing a significant financial burden on patients. This cost factor not only limits the market penetration of advanced cartilage repair treatments but also encourages patients to opt for less effective, conservative treatment options like pain management and physical therapy.

Market Trends of the Global Cartilage Repair Market

A notable trend in the global cartilage repair market is the growing demand for minimally invasive techniques. Patients and healthcare providers are increasingly favoring procedures that involve smaller incisions, less tissue damage, and shorter recovery periods. Minimally invasive surgeries, such as arthroscopic microfracture and osteochondral autograft transfer, are gaining traction due to their ability to repair cartilage while minimizing the risks associated with traditional open surgeries. These procedures not only lead to quicker rehabilitation but also reduce the likelihood of complications such as infection or blood loss. Furthermore, technological advancements, including the use of robotics and image-guided systems, have improved the precision and success rates of these surgeries. As patient preferences shift toward less invasive options, medical device manufacturers are developing new tools and instruments to facilitate these procedures. This trend is expected to drive further innovations in cartilage repair, leading to improved patient outcomes and expanding the market in the coming years.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Supply Chain Analysis
  • Regulatory Landscape
  • Patent Analysis
  • Technology Analysis

Cartilage Repair Market, By Treatment Modality

  • Market Overview
  • Cell-Based Cartilage Repair/Cartilage Regeneration
    • Chondrocyte Transplantation
    • Growth Factors
    • Stem Cells
  • Non-Cell-Based Cartilage Repair/Cartilage Regeneration
    • Tissue Scaffolds
    • Cell-Free Composites

Cartilage Repair Market, By Application Site

  • Market Overview
  • Knee
  • Hip
  • Ankle & Foot
  • Other Application Sites

Cartilage Repair Market, By Application

  • Market Overview
  • Hyaline Cartilage
  • Fibrocartilage

Cartilage Repair Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • DePuy Synthes (Johnson & Johnson)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vericel Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Osiris Therapeutics Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Histogenics Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anika Therapeutics Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arthrex Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CONMED Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orthocell Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RTI Surgical Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEDIPOST Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CellGenix GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tissue Regenix Group plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CollPlant Biotechnologies Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ISTO Technologies Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MTF Biologics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CartiHeal Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments